Eyevensys
Gina has a broad range of experience as a strategic business partner, including leading and overseeing the administration, financial planning, budgeting, human resources, and IT systems of both large global and French-based startup non-pharmaceutical companies. Before joining Eyevensys, Gina oversaw the finances and operations of an investment tax exemption program at The Moorings. Subsequently, and for more than 10 years, she was responsible for coordinating infrastructure, financial planning, and headcount reporting at a tech startup. Gina’s management of strategic corporate efforts, including the development of exit scenarios for IPO and M&A, led to the successful €175 M acquisition of Netcentrex. She then joined Emerson, a multinational company, where she was in charge of managing budgets and integrating new EMEA acquisitions into the global company portfolio. Gina holds a master’s degree in finance management and an Executive MBA from ESG Paris Business School.
This person is not in any teams
This person is not in any offices
Eyevensys
Eyevensys is a clinical stage, private, biotechnology company developing its innovative EyeCET platform to enable the sustained intraocular production of therapeutic proteins to treat a broad range of ophthalmic disease.